Diego A Pedroza

7PUBLICATIONS
28CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunologyPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 17, 2026
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.

|Jan 03, 2026
Anti-CSF-1R therapy with combined immuno-chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched triple negative breast cancers.

Diego A Pedroza, Xueying Yuan, Fengshuo Liu

|Jun 26, 2025
Anti-CSF-1R therapy with combined immuno- chemotherapy coordinate an adaptive immune response to eliminate macrophage enriched Triple Negative Breast Cancers.

Diego A Pedroza, Xueying Yuan, Fengshuo Liu

|May 07, 2024
CBP/P300 BRD Inhibition Reduces Neutrophil Accumulation and Activates Antitumor Immunity in TNBC.

Xueying Yuan, Xiaoxin Hao, Hilda L Chan

|Apr 20, 2022
Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.

Swarnima Singh, Nigel Lee, Diego A Pedroza

|Jul 02, 2021
Pregnancy Inhibits Mammary Carcinogenesis by Persistently Altering the Hypothalamic-Pituitary Axis.

Ramadevi Subramani, Adriana Estrada, Madeline Dixon

Pageof 2

Frequent Collaborators

5 joint publications

Jeffrey M Rosen

4 joint publications

Na Zhao

4 joint publications

Xiang H-F Zhang

3 joint publications

Fengshuo Liu